AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
INACTIVATION OF HIV-1 INFECTIVITY WITH PRESERVATION OF CONFORMATIONALAND FUNCTIONAL INTEGRITY OF VIRION SURFACE-PROTEINS
Authors: LIFSON JD ROSSIO JL ESSER MT SCHNEIDER DK BESS JW GRIMES MK ARTHUR LO HENDERSEN LE
Citation: Jd. Lifson et al., INACTIVATION OF HIV-1 INFECTIVITY WITH PRESERVATION OF CONFORMATIONALAND FUNCTIONAL INTEGRITY OF VIRION SURFACE-PROTEINS, The FASEB journal, 12(4), 1998, pp. 1724-1724
ADMINISTRATION OF 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) FOR PREVENTION OF PERINATAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES
Authors: VANROMPAY KKA MARTHAS ML LIFSON JD BERARDI CJ VASQUEZ GM AGATEP E DEHQANZADA ZA CUNDY KC BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., ADMINISTRATION OF 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) FOR PREVENTION OF PERINATAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES, AIDS research and human retroviruses, 14(9), 1998, pp. 761-773
CHEMICAL INACTIVATION OF RETROVIRAL INFECTIVITY BY TARGETING NUCLEOCAPSID PROTEIN ZINC FINGERS - A CANDIDATE SIV VACCINE
Authors: ARTHUR LO BESS JW CHERTOVA EN ROSSIO JL ESSER MT BENVENISTE RE HENDERSON LE LIFSON JD
Citation: Lo. Arthur et al., CHEMICAL INACTIVATION OF RETROVIRAL INFECTIVITY BY TARGETING NUCLEOCAPSID PROTEIN ZINC FINGERS - A CANDIDATE SIV VACCINE, AIDS research and human retroviruses, 14, 1998, pp. 311-319
PLASMA SIV RNA VIRAL LOAD DETERMINATION BY REAL-TIME QUANTIFICATION OF PRODUCT GENERATION IN REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION
Authors: SURYANARAYANA K WILTROUT TA VASQUEZ GM HIRSCH VM LIFSON JD
Citation: K. Suryanarayana et al., PLASMA SIV RNA VIRAL LOAD DETERMINATION BY REAL-TIME QUANTIFICATION OF PRODUCT GENERATION IN REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION, AIDS research and human retroviruses, 14(2), 1998, pp. 183-189
EFFECTIVENESS OF POSTINOCULATION (R)-9-(2-PHOSPHONYLMETHOXYPROPYL) ADENINE TREATMENT FOR PREVENTION OF PERSISTENT SIMIAN IMMUNODEFICIENCY VIRUS SIVMNE INFECTION DEPENDS CRITICALLY ON TIMING OF INITIATION AND DURATION OF TREATMENT
Authors: TSAI CC EMAU P FOLLIS KE BECK TW BENVENISTE RE BISCHOFBERGER N LIFSON JD MORTON WR
Citation: Cc. Tsai et al., EFFECTIVENESS OF POSTINOCULATION (R)-9-(2-PHOSPHONYLMETHOXYPROPYL) ADENINE TREATMENT FOR PREVENTION OF PERSISTENT SIMIAN IMMUNODEFICIENCY VIRUS SIVMNE INFECTION DEPENDS CRITICALLY ON TIMING OF INITIATION AND DURATION OF TREATMENT, Journal of virology, 72(5), 1998, pp. 4265-4273
IDENTIFICATION OF HIGHLY ATTENUATED MUTANTS OF SIMIAN IMMUNODEFICIENCY VIRUS
Authors: DESROSIERS RC LIFSON JD GIBBS JS CZAJAK SC HOWE AYM ARTHUR LO JOHNSON RP
Citation: Rc. Desrosiers et al., IDENTIFICATION OF HIGHLY ATTENUATED MUTANTS OF SIMIAN IMMUNODEFICIENCY VIRUS, Journal of virology, 72(2), 1998, pp. 1431-1437
CD4(-LYMPHOCYTE DEPLETION IN HUMAN LYMPHOID-TISSUE EX-VIVO IS NOT INDUCED BY NONINFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRIONS() T)
Authors: SYLWESTER AW GRIVEL JC FITZGERALD W ROSSIO JL LIFSON JD MARGOLIS LB
Citation: Aw. Sylwester et al., CD4(-LYMPHOCYTE DEPLETION IN HUMAN LYMPHOID-TISSUE EX-VIVO IS NOT INDUCED BY NONINFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRIONS() T), Journal of virology (Print), 72(11), 1998, pp. 9345-9347
INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIVITY WITH PRESERVATION OF CONFORMATIONAL AND FUNCTIONAL INTEGRITY OF VIRION SURFACE-PROTEINS
Authors: ROSSIO JL ESSER MT SURYANARAYANA K SCHNEIDER DK BESS JW VASQUEZ GM WILTROUT TA CHERTOVA E GRIMES MK SATTENTAU Q ARTHUR LO HENDERSON LE LIFSON JD
Citation: Jl. Rossio et al., INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIVITY WITH PRESERVATION OF CONFORMATIONAL AND FUNCTIONAL INTEGRITY OF VIRION SURFACE-PROTEINS, Journal of virology, 72(10), 1998, pp. 7992-8001
THE EXTENT OF EARLY VIRAL REPLICATION IS A CRITICAL DETERMINANT OF THE NATURAL-HISTORY OF SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION
Authors: LIFSON JD NOWAK MA GOLDSTEIN S ROSSIO JL KINTER A VASQUEZ G WILTROUT TA BROWN C SCHNEIDER D WAHL L LLOYD AL WILLIAMS J ELKINS WR FAUCI AS HIRSCH VM
Citation: Jd. Lifson et al., THE EXTENT OF EARLY VIRAL REPLICATION IS A CRITICAL DETERMINANT OF THE NATURAL-HISTORY OF SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION, Journal of virology, 71(12), 1997, pp. 9508-9514
VIRAL DYNAMICS OF PRIMARY VIREMIA AND ANTIRETROVIRAL THERAPY IN SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION
Authors: NOWAK MA LLOYD AL VASQUEZ GM WILTROUT TA WAHL LM BISCHOFBERGER N WILLIAMS J KINTER A FAUCI AS HIRSCH VM LIFSON JD
Citation: Ma. Nowak et al., VIRAL DYNAMICS OF PRIMARY VIREMIA AND ANTIRETROVIRAL THERAPY IN SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION, Journal of virology, 71(10), 1997, pp. 7518-7525
MOLECULAR-CLONING AND DISEASE ASSOCIATION OF HEPATITIS-G VIRUS - A TRANSFUSION-TRANSMISSIBLE AGENT
Authors: LINNEN J WAGES J ZHANGKECK ZY FRY KE KRAWCZYNSKI KZ ALTER H KOONIN E GALLAGHER M ALTER M HADZIYANNIS S KARAYIANNIS P FUNG K NAKATSUJI Y SHIH JWK YOUNG L PIATAK M HOOVER C FERNANDEZ J CHEN S ZOU JC MORRIS T HYAMS KC ISMAY S LIFSON JD HESS G FOUNG SKH THOMAS H BRADLEY D MARGOLIS H KIM JP
Citation: J. Linnen et al., MOLECULAR-CLONING AND DISEASE ASSOCIATION OF HEPATITIS-G VIRUS - A TRANSFUSION-TRANSMISSIBLE AGENT, Science, 271(5248), 1996, pp. 505-508
PATTERNS OF VIRAL REPLICATION CORRELATE WITH OUTCOME IN SIMIAN IMMUNODEFICIENCY VIRUS (SIV)-INFECTED MACAQUES - EFFECT OF PRIOR IMMUNIZATION WITH A TRIVALENT SIV VACCINE IN MODIFIED VACCINIA VIRUS ANKARA
Authors: HIRSCH VM FUERST TR SUTTER G CARROLL MW YANG LC GOLDSTEIN S PIATAK M ELKINS WR ALVORD WG MONTEFIORI DC MOSS B LIFSON JD
Citation: Vm. Hirsch et al., PATTERNS OF VIRAL REPLICATION CORRELATE WITH OUTCOME IN SIMIAN IMMUNODEFICIENCY VIRUS (SIV)-INFECTED MACAQUES - EFFECT OF PRIOR IMMUNIZATION WITH A TRIVALENT SIV VACCINE IN MODIFIED VACCINIA VIRUS ANKARA, Journal of virology, 70(6), 1996, pp. 3741-3752
ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED
Authors: KAPPES JC SAAG MS SHAW GM HAHN BH CHOPRA P CHEN QD EMINI EA MCFARLAND R YANG LC PIATAK M LIFSON JD
Citation: Jc. Kappes et al., ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 139-149
CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA
Authors: CAO YZ HO DD TODD J KOKKA R URDEA M LIFSON JD PIATAK M CHEN S HAHN BH SAAG MS SHAW GM
Citation: Yz. Cao et al., CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA, AIDS research and human retroviruses, 11(3), 1995, pp. 353-361
PREVENTION OF AIDS TRANSMISSION THROUGH SCREENING OF THE BLOOD-SUPPLY
Authors: GALEL SA LIFSON JD ENGLEMAN EG
Citation: Sa. Galel et al., PREVENTION OF AIDS TRANSMISSION THROUGH SCREENING OF THE BLOOD-SUPPLY, Annual review of immunology, 13, 1995, pp. 201-227
ANTIVIRAL AGENTS REDUCE VIRAL LOAD AND DELAY THE DETECTION OF INFECTED-CELLS IN-VIVO IN THE HIV-INFECTED HUPBMC-SCID MOUSE MODEL
Authors: BLACK PL BROUD DD WOOD OL KUNDER SC DAILEY PJ WILBER JC YANG LM PIATAK M LIFSON JD USSERY MA
Citation: Pl. Black et al., ANTIVIRAL AGENTS REDUCE VIRAL LOAD AND DELAY THE DETECTION OF INFECTED-CELLS IN-VIVO IN THE HIV-INFECTED HUPBMC-SCID MOUSE MODEL, Journal of cellular biochemistry, 1995, pp. 186-186
HEPATITIS-G VIRUS-INFECTION IN PATIENTS WITH ACUTE AND CHRONIC LIVER-DISEASE OF UNKNOWN ETIOLOGY
Authors: JEFFERS LJ PIATAK M BERNSTEIN DE REDDY KR LIFSON JD YUN A COELHOLITTLE E DEMEDINA M KIM JP SCHIFF ER
Citation: Lj. Jeffers et al., HEPATITIS-G VIRUS-INFECTION IN PATIENTS WITH ACUTE AND CHRONIC LIVER-DISEASE OF UNKNOWN ETIOLOGY, Hepatology, 22(4), 1995, pp. 302-302
VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: WEI XP GHOSH SK TAYLOR ME JOHNSON VA EMINI EA DEUTSCH P LIFSON JD BONHOEFFER S NOWAK MA HAHN BH SAAG MS SHAW GM
Citation: Xp. Wei et al., VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Nature, 373(6510), 1995, pp. 117-122
CD4(81-92) PEPTIDES BLOCK INFECTION BY PEDIATRIC CLINICAL ISOLATES OFHIV-1 RESISTANT TO NEUTRALIZATION BY SCD4
Authors: RAUSCH DM EIDEN LE KALYANARAMAN VS LIFSON JD
Citation: Dm. Rausch et al., CD4(81-92) PEPTIDES BLOCK INFECTION BY PEDIATRIC CLINICAL ISOLATES OFHIV-1 RESISTANT TO NEUTRALIZATION BY SCD4, AIDS research and human retroviruses, 10, 1994, pp. 190000026-190000026
QC-PCR FOR MONITORING OF HIV-1 VIRAL LOAD IN PLASMA IN RESPONSE TO ANTIRETROVIRAL TREATMENT
Authors: PIATAK M SAAG MS YANG LC KAPPES JC LUK KC EMINI EA SHAW GM LIFSON JD
Citation: M. Piatak et al., QC-PCR FOR MONITORING OF HIV-1 VIRAL LOAD IN PLASMA IN RESPONSE TO ANTIRETROVIRAL TREATMENT, AIDS research and human retroviruses, 10, 1994, pp. 190000077-190000077
NONCYTOLYTIC CD8 T-CELL ANTI-HIV RESPONSES IN PRIMARY HIV-1 INFECTION
Authors: MACKEWICZ CE YANG LC LIFSON JD LEVY JA
Citation: Ce. Mackewicz et al., NONCYTOLYTIC CD8 T-CELL ANTI-HIV RESPONSES IN PRIMARY HIV-1 INFECTION, Lancet, 344(8938), 1994, pp. 1671-1673
SAFETY, ACTIVITY, AND PHARMACOKINETICS OF GLQ223 IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX
Authors: KAHN JO GORELICK KJ GATTI G ARRI CJ LIFSON JD GAMBERTOGLIO JG BOSTROM A WILLIAMS R
Citation: Jo. Kahn et al., SAFETY, ACTIVITY, AND PHARMACOKINETICS OF GLQ223 IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 260-267
BINDING INTERACTIONS BETWEEN PEPTIDES CORRESPONDING TO THE CDR3 REGION OF CD4 AND HIV-1 GP120 AS STUDIED BY BIOSPECIFIC INTERACTION ANALYSIS
Authors: VANCOTT TC RAUSCH DM BETHKE FR KALYANARAMAN VS LIFSON JD REDFIELD RR EIDEN LE
Citation: Tc. Vancott et al., BINDING INTERACTIONS BETWEEN PEPTIDES CORRESPONDING TO THE CDR3 REGION OF CD4 AND HIV-1 GP120 AS STUDIED BY BIOSPECIFIC INTERACTION ANALYSIS, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 705-705
DEFINING MULTISITE INTERACTIONS BETWEEN HIV-1 GP120 AND CD4 DURING VIRAL ENTRY AND FUSION
Authors: RAUSCH DM VANCOTT TC EIDEN LE PADGETT MP KALYANARAMAN VS LIFSON JD
Citation: Dm. Rausch et al., DEFINING MULTISITE INTERACTIONS BETWEEN HIV-1 GP120 AND CD4 DURING VIRAL ENTRY AND FUSION, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 705-705
THE USE OF QUANTITATIVE COMPETITIVE PCR (QC-PCR) AS A MEASUREMENT OF ANTIRETROVIRAL DRUG ACTIVITY
Authors: SAAG MS PIATAK M KAPPES JC CLARK SJ LUK KC YANG LM HAHN BH EMINI EA LIFSON JD SHAW GM
Citation: Ms. Saag et al., THE USE OF QUANTITATIVE COMPETITIVE PCR (QC-PCR) AS A MEASUREMENT OF ANTIRETROVIRAL DRUG ACTIVITY, Journal of cellular biochemistry, 1993, pp. 3-3
Risultati: 1-25 | 26-30